Reta (GLP3) 5 mg, 10mg, 15 mg

Key Benefits & Applications

• Appetite Suppression Studies: Engages central GLP‑1 pathways to reduce feeding signals.
• Metabolic Rate Modulation: Activates glucagon receptors to enhance lipid and glucose utilization.
• Glycemic Control Research: Stimulates GIP receptors to improve insulin secretion dynamics.
• Obesity & Diabetes Models: Ideal for in vitro and in vivo assays exploring weight‑loss and glycemic‑regulation mechanisms.

Research‑Grade Specifications

• Form: Lyophilized powder for long‑term stability
• Purity: ≥98% as verified by third‑party HPLC and MS analysis
• Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
• Molecular Weight:33 g/mol
• CAS Number: 2381089‑83‑2
• Synonyms: LY‑3437943
• Vial Volume: 3 mL vial containing 5 mg lyophilized GLP‑3, 5 mL vial containing 15 mg lyophilized GLP‑3

Handling & Storage

• Lyophilized Powder: Store sealed in a freezer at or below –4 °F (–20 °C) away from light to preserve peptide integrity. Lyophilized powder is stable up to 24 months under proper conditions.
• Reconstituted Solution: Refrigerate at 6–46.4 °F (2–8 °C) and use within 4 weeks to maintain activity.
• Reconstitution: Add 1 to 2 mL bacteriostatic water; gently swirl until fully dissolved.

Quality Assurance

• Each lot undergoes rigorous HPLC analysis and mass spectrometry to confirm identity and purity.
• COAs are available for download, ensuring transparency and confidence in your research materials.
• Third‑party tested in GMP certified leading U.S. labs.

Legal Disclaimer

All products are for laboratory research purposes only. Not for human consumption, medical, or veterinary use. The Peptique does not condone or support the use of peptides outside of controlled scientific research. By purchasing, you acknowledge that you are a qualified researcher or institution. You must be 21 or older.

COA-C-RETA15-101025 ENDO-C-RETA15-101025

COA-C-RETA10-103725 ENDO-C-RETA10-103725